Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency

Kemp, John P., Smith, Paul M., Pyle, Angela, Neeve, Vivienne C. M., Tuppen, Helen A. L., Schara, Ulrike, Talim, Beril, Topaloglu, Haluk, Holinski-Feder, Elke, Abicht, Angela, Czermin, Birgit, Lochmuller, Hanns, McFarland, Robert, Chinnery, Patrick F., Chrzanowska-Lightowlers, Zofia M. A., Lightowlers, Robert N., Taylor, Robert W. and Horvath, Rita (2011) Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain, 134 1: 183-195. doi:10.1093/brain/awq320


Author Kemp, John P.
Smith, Paul M.
Pyle, Angela
Neeve, Vivienne C. M.
Tuppen, Helen A. L.
Schara, Ulrike
Talim, Beril
Topaloglu, Haluk
Holinski-Feder, Elke
Abicht, Angela
Czermin, Birgit
Lochmuller, Hanns
McFarland, Robert
Chinnery, Patrick F.
Chrzanowska-Lightowlers, Zofia M. A.
Lightowlers, Robert N.
Taylor, Robert W.
Horvath, Rita
Title Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency
Journal name Brain   Check publisher's open access policy
ISSN 0006-8950
1460-2156
Publication date 2011
Year available 2011
Sub-type Article (original research)
DOI 10.1093/brain/awq320
Open Access Status
Volume 134
Issue 1
Start page 183
End page 195
Total pages 13
Place of publication Oxford, United Kingdom
Publisher Oxford University Press
Collection year 2012
Language eng
Subject 2728 Clinical Neurology
Abstract Mutations in several mitochondrial DNA and nuclear genes involved in mitochondrial protein synthesis have recently been reported in combined respiratory chain deficiency, indicating a generalized defect in mitochondrial translation. However, the number of patients with pathogenic mutations is small, implying that nuclear defects of mitochondrial translation are either underdiagnosed or intrauterine lethal. No comprehensive studies have been reported on large cohorts of patients with combined respiratory chain deficiency addressing the role of nuclear genes affecting mitochondrial protein synthesis to date. We investigated a cohort of 52 patients with combined respiratory chain deficiency without causative mitochondrial DNA mutations, rearrangements or depletion, to determine whether a defect in mitochondrial translation defines the pathomechanism of their clinical disease. We followed a combined approach of sequencing known nuclear genes involved in mitochondrial protein synthesis (EFG1, EFTu, EFTs, MRPS16, TRMU), as well as performing in vitro functional studies in 22 patient cell lines. The majority of our patients were children (<15 years), with an early onset of symptoms <1 year of age (65). The most frequent clinical presentation was mitochondrial encephalomyopathy (63); however, a number of patients showed cardiomyopathy (33), isolated myopathy (15) or hepatopathy (13). Genomic sequencing revealed compound heterozygous mutations in the mitochondrial transfer ribonucleic acid modifying factor (TRMU) in a single patient only, presenting with early onset, reversible liver disease. No pathogenic mutation was detected in any of the remaining 51 patients in the other genes analysed. In vivo labelling of mitochondrial polypeptides in 22 patient cell lines showed overall (three patients) or selective (four patients) defects of mitochondrial translation. Immunoblotting for mitochondrial proteins revealed decreased steady state levels of proteins in some patients, but normal or increased levels in others, indicating a possible compensatory mechanism. In summary, candidate gene sequencing in this group of patients has a very low detection rate (1/52), although in vivo labelling of mitochondrial translation in 22 patient cell lines indicate that a nuclear defect affecting mitochondrial protein synthesis is responsible for about one-third of combined respiratory chain deficiencies (7/22). In the remaining patients, the impaired respiratory chain activity is most likely the consequence of several different events downstream of mitochondrial translation. Clinical classification of patients with biochemical analysis, genetic testing and, more importantly, in vivo labelling and immunoblotting of mitochondrial proteins show incoherent results, but a systematic review of these data in more patients may reveal underlying mechanisms, and facilitate the identification of novel factors involved in combined respiratory chain deficiency.
Keyword Combined respiratory chain deficiency
Early onset encephalomyopathy
Mitochondrial translation
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: UQ Diamantina Institute Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 42 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 43 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 11 Jun 2014, 11:37:47 EST by Kylie Hengst on behalf of UQ Diamantina Institute